Anesiva moves closer to merger
Pain drug business Anesiva Inc. moved a step closer to its proposed merger with Baltimore's Arcion Therapeutics Inc.
Ligand Pharmaceuticals, a biotechnology company, and Neurogen, a drug development company, have amended their merger agreement to increase the merger consideration payable.